Results 111 to 120 of about 4,756,303 (211)
Long‐term survival after surgical removal of an intermediate grade pancreatic carcinoma in a cat
Abstract An 11‐year‐old male neutered domestic shorthair cat presented with a history of acute diarrhoea, decreased appetite, and a palpable abdominal mass. Following clinical staging and histopathological examination after partial pancreatectomy, the cat was diagnosed with a completely excised intermediate grade pancreatic carcinoma without evidence ...
Abel Verbrugghe +4 more
wiley +1 more source
TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma [PDF]
Proliferation and survival of Hodgkin and Reed/Sternberg (HRS) cells, the malignant cells of classical Hodgkin lymphoma (cHL), are dependent on constitutive activation of nuclear factor {kappa}B (NF-{kappa}B).
Inga Vater +25 more
core +1 more source
New insights into the Bortezomib‐induced cytotoxic and resistance mechanisms in a primary effusion lymphoma mouse model [PDF]
Primary effusion lymphoma (PEL) is an aggressive non‐Hodgkin Bcell lymphoma associated to Kaposi's sarcoma‐associated herpes-virus (KSHV), for which there is not an optimal therapy yet.
D'Orazi, Gabriella +11 more
core +1 more source
Abstract A 15‐year‐2‐month‐old, male, neutered domestic shorthair cat was presented for a 1‐week history of increased respiratory effort and declining appetite. Point‐of‐care ultrasound diagnosed tri‐cavitary effusion, and echocardiography revealed the presence of multiple free‐floating hyperechoic nodules within the pericardium.
Maximiliane Gabriele Sehn +4 more
wiley +1 more source
Primary effusion lymphoma (PEL) or body cavity lymphoma is a rare type of extra nodal lymphoma of B-cell origin that presents as lymphomatous effusion(s) without any nodal enlargement or tumor masses. It belongs to the group of AIDS related non-Hodgkin’s
Farhan Mohammad +5 more
doaj +1 more source
In this analysis of a diverse cohort of 500 patients with previously untreated DLBCL in a real‐world clinical setting, Pola‐R‐CHP demonstrated high response rates at end‐of‐treatment, which were consistent among the overall population, in patients > 80 years and regardless of International Prognostic Index status and cell of origin subtypes.
Takahiro Kumode +21 more
wiley +1 more source
Malignant lymphoma, presenting as primary intra-cardiac mass, is rare in children. Without timely intervention, morbidity and mortality may be high in this condition, particularly when it is associated with pericardial effusion and cardiac tamponade ...
Adefehinti O +4 more
doaj
33‐year‐old HIV‐positive patient presenting with primary effusion lymphoma
Key Clinical Message Our patient presenting with symptoms of shortness of breath and fever, noncompliant with antiretroviral therapy was found to have a rare HIV‐associated non‐Hodgkin's lymphoma that carries a dismal prognosis. Early recognition of this
Ihtesham A. Qureshi +3 more
doaj +1 more source
Unmasking the Influence of Viral Micro‐RNAs on Host Immunity
Viral micro‐RNAs are increasingly recognized as key modulators of host–virus interactions. They influence multiple immune functions, including antigen presentation, T‐cell activation, and cytokine signaling, while also tuning viral gene expression to promote persistence.
Riley J. K. Easton +1 more
wiley +1 more source
Primary Effusion Lymphoma Complicated by Hepatitis B Virus-Induced Liver Cirrhosis and Acquired Immunodeficiency Syndrome [PDF]
Primary effusion lymphoma (PEL) is a rare subset of non-Hodgkin’s lymphoma that predominantly grows in body cavities as neoplastic effusions without a contiguous tumor mass. Most PEL cases occur in an immunocompromised state, such as AIDS.
高橋, 寧史 +11 more
core +1 more source

